Hap Trading, LLC Sage Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $1.85 Million - $2.35 Million	49,900 Added 375.19%	63,200 $4,000
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $324,927 - $493,355	-7,900 Reduced 37.26%	13,300 $83,000
Q2 2020 Aug 10, 2020	BUY	$25.95 - $43.15 $550,140 - $914,780	21,200 New	21,200 $85,000
Q1 2020 May 08, 2020	SELL	$26.15 - $77.24 $3.67 Million - $10.9 Million	-140,500 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$60.18 - $154.77 $4.28 Million - $11 Million	71,100 Added 102.45%	140,500 $77,000
Q3 2019 Nov 12, 2019	BUY	$140.29 - $189.96 $4.73 Million - $6.4 Million	33,700 Added 94.4%	69,400 $199,000
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $3 Million - $3.48 Million	19,000 Added 113.77%	35,700 $758,000
Q1 2019 May 10, 2019	SELL	$89.33 - $163.65 $7.24 Million - $13.3 Million	-81,000 Reduced 82.91%	16,700 $230,000
Q4 2018 Feb 12, 2019	BUY	$81.94 - $139.71 $8.01 Million - $13.6 Million	97,700 New	97,700 $267,000
Q3 2018 Nov 09, 2018	SELL	$138.11 - $169.04 $1.67 Million - $2.05 Million	-12,100 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$140.36 - $175.76 $2.27 Million - $2.85 Million	-16,200 Reduced 57.24%	12,100 $96,000
Q1 2018 May 11, 2018	SELL	$152.15 - $192.33 $16 Million - $20.3 Million	-105,300 Reduced 78.82%	28,300 $854,000
Q3 2017 Nov 08, 2017	BUY	$61.4 - $88.52 $8.2 Million - $11.8 Million	133,600	133,600 $345,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.